Dechra Veterinary Products

Dechra is committed to helping you care for animals. We do this by providing quality products and the very highest level of support. Our companion animal portfolio focuses on endocrinology, anesthesia/analgesia, oncology, dermatology, kidney health, ophthalmology, fluid therapy, anti-infectives, joint health, and dental care. Dechra’s key brands include Zenalpha® (medetomidine and vatinoxan hydrochlorides injection), Laverdia®-CA1 (verdinexor tablets), Vetoryl® Capsules (trilostane), Zycortal® Suspension (desoxycorticosterone pivalate injectable suspension), and Osurnia® (florfenicol, terbinafine, betamethasone acetate). Dechra’s rapid growth is fueled by these key products and others in the portfolio, as well as recent highly successful acquisitions, including Putney (2016), Piedmont (2022), and Med-Pharmex (2022). We continue to grow because we understand the challenges veterinarians face and we give them what they need. For more information, please visit www.dechra-us.com or call (866) 933-2472